ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,201Medicare Part D Prescriptions Filled, Including Refills

Rank: 148 out of 2604

$588K Total Retail Price of All Prescriptions

Rank: 127 out of 2604

734 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 734 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

18% of this provider’s 734 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 6,372 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
OMEPRAZOLE 345 252 1 5
SIMVASTATIN 333 265 2 2
HYDROCODONE-ACETAMINOPHEN 317 184 S3 3 1
LISINOPRIL 296 227 4 3
LEVOTHYROXINE SODIUM 280 222 5 4
METFORMIN HCL 262 208 6 7
METOPROLOL TARTRATE 215 161 7 9
AMLODIPINE BESYLATE 206 173 8 6
FUROSEMIDE 185 143 9 8
CARVEDILOL 139 99 10 26
LOVASTATIN 139 108 10 24
GABAPENTIN 122 51 12 12
ISOSORBIDE MONONITRATE ER 121 95 13 38
CITALOPRAM HBR 118 70 14 18
ATENOLOL 116 90 15 11
WARFARIN SODIUM 115 112 16 13
POTASSIUM CHLORIDE 109 87 17 16
BUMETANIDE 98 86 18 70
TAMSULOSIN HCL 96 80 19 30
PROAIR HFA 89 36 20 27
TRAMADOL HCL 85 72 21 15
ATORVASTATIN CALCIUM 84 67 22 19
GLIMEPIRIDE 80 71 23 57
SERTRALINE HCL 79 39 24 23
ENALAPRIL MALEATE 77 63 25 50
HYDROCHLOROTHIAZIDE 74 61 26 10
ALENDRONATE SODIUM 73 57 27 29
PLAVIX 72 57 28 75
PREDNISONE 72 40 28 34
CLOPIDOGREL 71 52 30 39
LOSARTAN POTASSIUM 66 66 31 20
DONEPEZIL HCL 60 60 32 28
PAROXETINE HCL 58 39 33 62
LANTUS 58 36 33 40
RAMIPRIL 57 40 35 111
ZOLPIDEM TARTRATE 57 31 35 21
ACETAMINOPHEN-CODEINE 54 34 S3 37 60
NEXIUM 54 26 37 53
CYCLOBENZAPRINE HCL 52 0 R 39 43
MORPHINE SULFATE ER 51 19 S2 40 58
TRIAMTERENE-HCTZ 51 48 40 55
CYMBALTA 50 24 42 44
DIGOXIN 50 28 42 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 11, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.